MSK Report News

Tuesday, October 20, 2009 ACR 2009: Infliximab Plus MTX for JIA
Infliximab plus methotrexate (MTX) bests combinations of traditional disease modifying drugs and/or MTX alone for the treatment of polyarticular juvenile idiopathic arthritis...

Monday, October 19, 2009 BioPharm Business News and Perspectives: Denosumab Approval Faces Delay
FDA-watchers predict that the agency will miss the October 19th target set for denosumab approval by as much as 3 months...

Monday, October 19, 2009 Procedures: Experts Call for Early Intervention with Hip Scopes
As presented at the annual meeting of the International Society for Hip Arthroscopy, earlier intervention is better when it comes to joint-sparing hip operations...

Friday, October 16, 2009 Procedures: EMG Finds “High Risk” Zone for ACL Tears in Female Athletes
Reduced semitendinosus (ST) and elevated vastus lateralis (VL) activity increase the risk of ACL tear—and taking bits from the ST for ACL repair is probably a mistake...

Thursday, October 15, 2009 Procedures: To Scope or Not to Scope in Hip Patients Over 60
Hip arthroscopy may benefit some patients aged 60 and older with femoroacetebular impingement...

Wednesday, October 14, 2009 Autoimmunity: Research Breakthrough: Common Retrovirus May Cause CFS
Two-thirds of chronic fatigue syndrome patients carry xenotropic murine leukemia virus-related virus (XMRV) in their blood...

Tuesday, October 13, 2009 BioPharm Business News and Perspectives: Protalix Reports First Data on Generic Enbrel™
Plant cell fusion protein would be first “biosimilar” version of etanercept...

Thursday, October 08, 2009 Consumer News: Second Knee Surgery Common Among Young Patients
Young people who have surgery to repair a damaged ACL will likely need additional surgery in the future...

Wednesday, October 07, 2009 Autoimmunity: Can Surgical Masks Protect You From Flu? Maybe
Surgical masks are nearly as effective as N95 respirators in preventing influenza in health care workers...

Wednesday, October 07, 2009 Autoimmunity: TNF Blockade in SLE? The Plot Thickens
Brief therapy with 4 infusions of infliximab plus azathioprine produces relatively safe, durable improvements in refractory lupus nephritis...